Belmont Capital’s QuidelOrtho QDEL Stock Holding History

Belmont Capital’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10	Closed	-$2K	–	67
2020 Q4	$2K	Hold	10	–	–	﹤0.01%	65
2020 Q3	$2K	Hold	10	–	–	﹤0.01%	53
2020 Q2	$2K	Buy	+10	New	+$1.57K	﹤0.01%	56

Other funds holding QDEL

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Belmont Capital's QDEL Position: Q1 2021 in Review

Belmont Capital sold out of QuidelOrtho (QDEL) in Q1 2021, closing a stake of 10 shares — an estimated $2K sold.

Belmont Capital first reported a position in QDEL in Q2 2020 and held it in 3 quarters. The position peaked at $2K in Q4 2020. 349 funds tracked by Wall St. Rank hold QDEL as of Q1 2021.

Belmont Capital reported no remaining QuidelOrtho position as of Q1 2021 after selling out during the quarter.
Belmont Capital sold 10 QuidelOrtho shares in Q1 2021, an estimated $2K.
Belmont Capital first reported a position in QuidelOrtho in Q2 2020 and held it in 3 quarters.
Belmont Capital's QuidelOrtho position peaked at $2K in Q4 2020.
349 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2021.

Based on Belmont Capital's 13F filing for Q1 2021, filed 28 Apr 2021.